MKI67 and ductal breast carcinoma in situ: To better illustrate the role of the proposed invasive carcinoma segmentation model in immunohistochemical quantification, we selected 29 cases of Ki-67-stained WSIs with IBC-NST, where the DCIS constituted more than 10% of the total tumor area.